94 related articles for article (PubMed ID: 16121693)
1. Oncolytic replicating virus therapy: is the time right?
Günzburg WH
Curr Opin Mol Ther; 2005 Aug; 7(4):291-2. PubMed ID: 16121693
[No Abstract] [Full Text] [Related]
2. Viral delivery for gene therapy against cell movement in cancer.
Wu TL; Zhou D
Adv Drug Deliv Rev; 2011 Jul; 63(8):671-7. PubMed ID: 21616108
[TBL] [Abstract][Full Text] [Related]
3. Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
Guse K; Dias JD; Bauerschmitz GJ; Hakkarainen T; Aavik E; Ranki T; Pisto T; Särkioja M; Desmond RA; Kanerva A; Hemminki A
Gene Ther; 2007 Jun; 14(11):902-11. PubMed ID: 17377596
[TBL] [Abstract][Full Text] [Related]
4. The potential impact of hypoxia on the success of oncolytic virotherapy.
Hay JG
Curr Opin Mol Ther; 2005 Aug; 7(4):353-8. PubMed ID: 16121701
[TBL] [Abstract][Full Text] [Related]
5. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
6. Naturally oncolytic viruses.
Roberts MS; Lorence RM; Groene WS; Bamat MK
Curr Opin Mol Ther; 2006 Aug; 8(4):314-21. PubMed ID: 16955694
[TBL] [Abstract][Full Text] [Related]
7. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
Bauzon M; Hermiston TW
Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
[TBL] [Abstract][Full Text] [Related]
8. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs fine-tune oncolytic viruses.
Bell JC; Kirn D
Nat Biotechnol; 2008 Dec; 26(12):1346-8. PubMed ID: 19060871
[No Abstract] [Full Text] [Related]
10. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
[TBL] [Abstract][Full Text] [Related]
11. Viral vectors as therapeutic agents for glioblastoma.
Aghi M; Rabkin S
Curr Opin Mol Ther; 2005 Oct; 7(5):419-30. PubMed ID: 16248277
[TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide allows for in vivo dose reduction of a potent oncolytic virus.
Kambara H; Saeki Y; Chiocca EA
Cancer Res; 2005 Dec; 65(24):11255-8. PubMed ID: 16357128
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy progress and prospects cancer: oncolytic viruses.
Liu TC; Kirn D
Gene Ther; 2008 Jun; 15(12):877-84. PubMed ID: 18418413
[TBL] [Abstract][Full Text] [Related]
14. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
15. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
[TBL] [Abstract][Full Text] [Related]
16. A pox on your tumor.
Williams DA
Mol Ther; 2006 Sep; 14(3):313. PubMed ID: 16844420
[No Abstract] [Full Text] [Related]
17. Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy.
Höti N; Chowdhury W; Hsieh JT; Sachs MD; Lupold SE; Rodriguez R
Mol Ther; 2006 Dec; 14(6):768-78. PubMed ID: 16990052
[TBL] [Abstract][Full Text] [Related]
18. Development of a second-generation oncolytic Herpes simplex virus expressing TNFalpha for cancer therapy.
Han ZQ; Assenberg M; Liu BL; Wang YB; Simpson G; Thomas S; Coffin RS
J Gene Med; 2007 Feb; 9(2):99-106. PubMed ID: 17256802
[TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus-based vectors for the treatment of cancer and neurodegenerative disease.
Latchman DS
Curr Opin Mol Ther; 2005 Oct; 7(5):415-8. PubMed ID: 16248276
[TBL] [Abstract][Full Text] [Related]
20. Development of transcriptionally regulated oncolytic adenoviruses.
Ko D; Hawkins L; Yu DC
Oncogene; 2005 Nov; 24(52):7763-74. PubMed ID: 16299536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
